NDC 51672-2075-01 - Bacitracin Zinc
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-2075
- Requested NDC
- 51672-2075-01
- Package NDCs from labels
- 51672-2075-1, 51672-2075-2, 51672-2075-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-08-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bacitracin Zinc - A-S Medication Solutions | A-S Medication Solutions | 2026-08-07 | HUMAN OTC DRUG LABEL |
| Bacitracin Zinc Ointment USP | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2026-04-10 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-2075-1 | Bacitracin Zinc | 15 g in 1 TUBE | OINTMENT | 15 | 6 | |
| 51672-2075-1 | Bacitracin Zinc | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-2075-2 | Bacitracin Zinc | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-2075-2 | Bacitracin Zinc | 30 g in 1 TUBE | OINTMENT | 30 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-2075 | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 4 | Current NDC, Legacy NDC, 4 package rows | 20241105_4afdeedf-9cdf-47d6-919f-ea907fda0290.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-2075-1 | GM - Gram | 51672-2075 | e945b097-4fbc-49ee-be04-cda62ddd0a1b | 1 | 2013-02-13 |
| 51672-2075-2 | GM - Gram | 51672-2075 | 9d1461f6-ec4f-41a4-abbd-699c44ef8cb8 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Bacitracin Zinc | ACTIVE INGREDIENT | 89Y4M234ES | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Bacitracin | ACTIVE MOIETY | 58H6RWO52I | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| mineral oil | INACTIVE INGREDIENT | T5L8T28FGP | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EA EIGHT HOUR SKIN PROTECTANT | PETROLATUM | REVLON | b590991c-8ec8-67c2-e053-2a95a90a3acf | 2025-08-01 | Warnings | 4T6H12BN9U |
| EIGHT HOUR SKIN FRAGRANCE FREE | PETROLATUM | REVLON | b61d6e2e-18dd-37d2-e053-2a95a90af57b | 2025-08-01 | Warnings | 4T6H12BN9U |
| Thera Plus Original Strength Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | FOURSTAR GROUP USA, INC. | 09e8bdb7-dc14-4f28-8306-c0e2bf73f081 | 2025-07-31 | Warnings | M004 89Y4M234ES |
| Asteroid | MENTHOL, PETROLATUM, ZINC OXIDE | HEALTHTEX LIMITED | 29d1e46d-0189-4f9e-9963-8a9de2757f28 | 2025-07-30 | Warnings | 4T6H12BN9U |
| Bacitracin | BACITRACIN | Bryant Ranch Prepack | 0c081802-429f-468f-9650-293cb7a1ad34 | 2025-07-29 | Warnings | M004 |
| LEADER Mineral Oil | MINERAL OIL | Cardinal Health, 110 dba Leader | 7d4f8fa3-8203-5523-e053-2991aa0aba1a | 2025-07-28 | Warnings | T5L8T28FGP |
| health and .beyond Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Nantong Health & Beyond Hygienic Products Inc. | 0070ea5f-434d-53a7-e063-6294a90abf18 | 2025-07-27 | Warnings | M004 89Y4M234ES |
| health and beyond TRIPLE ANTIBIOTIC | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Nantong Health & Beyond Hygienic Products Inc. | 13cbe416-a146-447d-be36-8b3af9b3c895 | 2025-07-27 | Warnings | M004 89Y4M234ES |
| AOSI HEALTHCARE TRIPLE ANTIBIOTIC | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Nantong Health & Beyond Hygienic Products Inc. | 70c53369-7cf6-4352-a19f-c85a55c5a4bd | 2025-07-27 | Warnings | M004 89Y4M234ES |
| ProCure SkinGuard | PETROLATUM 49.9% | Twin Med LLC | 3a1721f6-1bb0-cd47-e063-6394a90a148e | 2025-07-25 | Warnings | 4T6H12BN9U |
| ProCure HydroCerin | PETROLATUM 33% | Twin Med LLC | 3ab7248d-b914-9fdd-e063-6294a90ac4c8 | 2025-07-24 | Warnings | 4T6H12BN9U |
| AD PREVENT Original | AD PREVENT ORIGINAL | WellSpring Pharmaceutical Corporation | cf73246e-81c1-42e9-a107-dc6c99cf7d01 | 2025-07-24 | Warnings | 4T6H12BN9U |
| Dr Butlers Soothing Incontinence | MINERAL OIL 59.8%, PETROLATUM 36.0% | Beyond Health PA | 3a9d3796-fd05-fe57-e063-6294a90a0ac6 | 2025-07-23 | Warnings | 4T6H12BN9U T5L8T28FGP |
| A and D plus E | VITAMIN A, D AND E OINTMENT | Derma Sciences Canada Inc. | 35aca592-bfd0-652f-e063-6394a90ac53e | 2025-07-22 | Warnings | 4T6H12BN9U |
| Petroleum Jelly | PETROLATUM | Derma Sciences Canada Inc. | 3a895e6c-da8d-db9b-e063-6394a90ace40 | 2025-07-22 | Warnings | 4T6H12BN9U |
| Pomada de Sulfa | NEOMYCIN SULFATE | Menper Distributors, Inc. | 216f4d22-e5e8-46c8-a4ef-8d1532792b56 | 2025-07-22 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, AND POLYMYXIN B SULFATE | STRATEGIC SOURCING SERVICES LLC | 1bda9c30-8fc8-4814-b211-94550672b22f | 2025-07-21 | Warnings | M004 89Y4M234ES |
| Triple Antibiotic plus Pain Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | STRATEGIC SOURCING SERVICES LLC | 6a61c900-2dfc-4c07-8ae5-32ffbd89d2b6 | 2025-07-21 | Warnings | M004 89Y4M234ES |
| GoodSense Hemorrhoidal Pain Relief | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Perrigo Direct, Inc | 2e5f699d-45e8-6451-e063-6394a90a8ad8 | 2025-07-20 | Warnings | 4T6H12BN9U |
| Eyeleve MGD | MINERAL OIL | Bruder Healthcare | 145b66e2-00e1-410e-8539-e12ffc4f6f82 | 2025-07-15 | Warnings | T5L8T28FGP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.